SunWay Biotech , Ltd. Overview
Get informed when a big investor buys or sells
+ Follow26.80
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for 1271.TWO is 26.8. That is above the sector sector average of 24.62. Investors often review this figure alongside SunWay Biotech , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, 1271.TWO currently prints 26.8 for P/E ratio, while the sector average sits near 24.62. That is roughly 8.8% above the sector mean. Large gaps often invite a closer look at SunWay Biotech , Ltd.'s growth, margins, and balance sheet.
A P/E ratio of 26.8 for SunWay Biotech , Ltd. is not 'good' or 'bad' on its own. Compare it with the peer average (24.62) and with 1271.TWO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting 1271.TWO's P/E ratio (26.8), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
